49 related articles for article (PubMed ID: 17265116)
1. Emergence of secondary resistance to imatinib in recurrent gastric GIST.
Jayanthi NV
J Gastrointest Surg; 2010 Dec; 14(12):2018-9; author reply 2020. PubMed ID: 20714935
[No Abstract] [Full Text] [Related]
2. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132.
Wang D; Zhang Q; Blanke CD; Demetri GD; Heinrich MC; Watson JC; Hoffman JP; Okuno S; Kane JM; von Mehren M; Eisenberg BL
Ann Surg Oncol; 2012 Apr; 19(4):1074-80. PubMed ID: 22203182
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome.
Wang SY; Wu CE; Lai CC; Chen JS; Tsai CY; Cheng CT; Yeh TS; Yeh CN
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30934606
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
Eisenberg BL; Harris J; Blanke CD; Demetri GD; Heinrich MC; Watson JC; Hoffman JP; Okuno S; Kane JM; von Mehren M
J Surg Oncol; 2009 Jan; 99(1):42-7. PubMed ID: 18942073
[TBL] [Abstract][Full Text] [Related]
6. Strong Long-Term Survival with Targeted Therapy in Inoperable/Metastatic Gastrointestinal Stromal Tumors.
Tuta C; Vatu BI; Artene SA
Curr Health Sci J; 2020; 46(3):315-318. PubMed ID: 33304636
[TBL] [Abstract][Full Text] [Related]
7. The 100 Most Influential Papers and Recent Trends in the Field of Gastrointestinal Stromal Tumours: A Bibliometric Analysis.
Siddiq K; Akbar HF; Khan M; Siddiqui AA; Nusrat S; Blay JY
Cureus; 2018 Mar; 10(3):e2311. PubMed ID: 29755907
[TBL] [Abstract][Full Text] [Related]
8. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).
Tang S; Yin Y; Shen C; Chen J; Yin X; Zhang B; Yao Y; Yang J; Chen Z
World J Surg Oncol; 2017 Apr; 15(1):79. PubMed ID: 28399894
[TBL] [Abstract][Full Text] [Related]
9. Effective Downsizing of a Gastroesophageal GIST Using Neoadjuvant Imatinib Mesylate: a Case Report.
Asif S; Gupta N; Gupta G; Mehta A; Singh S
J Gastrointest Cancer; 2017 Jun; 48(2):198-200. PubMed ID: 27006070
[No Abstract] [Full Text] [Related]
10. A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report.
Yanagawa S; Tanabe K; Suzuki T; Tokumoto N; Arihiro K; Ohdan H
World J Surg Oncol; 2014 Feb; 12():47. PubMed ID: 24575748
[TBL] [Abstract][Full Text] [Related]
11. Prolonged Therapy with Imatinib Mesylate before Surgery for Advanced Gastrointestinal Stromal Tumor Results of a Phase II Trial.
Doyon C; Sidéris L; Leblanc G; Leclerc YE; Boudreau D; Dubé P
Int J Surg Oncol; 2012; 2012():761576. PubMed ID: 23316352
[TBL] [Abstract][Full Text] [Related]
12. Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.
Turley RS; Peng PD; Reddy SK; Barbas AS; Geller DA; Marsh JW; Tsung A; Pawlik TM; Clary BM
Cancer; 2012 Jul; 118(14):3571-8. PubMed ID: 22086856
[TBL] [Abstract][Full Text] [Related]
13. Resection combined with imatinib therapy for liver metastases of gastrointestinal stromal tumors.
Xia L; Zhang MM; Ji L; Li X; Wu XT
Surg Today; 2010 Oct; 40(10):936-42. PubMed ID: 20872196
[TBL] [Abstract][Full Text] [Related]
14. Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.
Sjölund K; Andersson A; Nilsson E; Nilsson O; Ahlman H; Nilsson B
World J Surg; 2010 Sep; 34(9):2090-7. PubMed ID: 20512492
[TBL] [Abstract][Full Text] [Related]
15. Complete resection after imatinib treatment of a gastrointestinal stromal tumor of the ileum with peritoneal metastases: report of a case.
Akiyoshi T; Oya M; Fujimoto Y; Kuroyanagi H; Ueno M; Yamaguchi T; Takahashi S; Hatake K; Katori M; Yamamoto N; Muto T
Surg Today; 2010 Mar; 40(3):272-6. PubMed ID: 20180084
[TBL] [Abstract][Full Text] [Related]
16. Downstaging of a rectal gastrointestinal stromal tumor by neoadjuvant imatinib therapy allowing for a conservative surgical approach.
Santos Fernandes Gd; Castro Cotti GC; Freitas D; Cutait R; Hoff PM
Clinics (Sao Paulo); 2009; 64(8):819-21. PubMed ID: 19690669
[No Abstract] [Full Text] [Related]
17. Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): racing against resistance.
Gold JS; Dematteo RP
Ann Surg Oncol; 2007 Apr; 14(4):1247-8. PubMed ID: 17265116
[No Abstract] [Full Text] [Related]
18. Gastrointestinal stromal tumour treated with neoadjuvant imatinib.
Loughrey MB; Mitchell C; Mann GB; Michael M; Waring PM
J Clin Pathol; 2005 Jul; 58(7):779-81. PubMed ID: 15976351
[TBL] [Abstract][Full Text] [Related]
19. A case of huge GIST of the stomach successfully resected following effective neoadjuvant chemotherapy.
Tanaka N; Saka M
Jpn J Clin Oncol; 2008 Nov; 38(11):790. PubMed ID: 18952707
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
